Biochip for K-ras mutation screening in ovarian cancer.

Clin Chem

Department of Obstetrics and Gynecology, Division of Gynecology, Medical University of Vienna, Vienna, Austria.

Published: April 2005

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2004.041194DOI Listing

Publication Analysis

Top Keywords

biochip k-ras
4
k-ras mutation
4
mutation screening
4
screening ovarian
4
ovarian cancer
4
biochip
1
mutation
1
screening
1
ovarian
1
cancer
1

Similar Publications

[Over-expression of circNR4A1/Hsa-circ-0026352 inhibits proliferation and induces apoptosis in MCF-7 cells].

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

December 2020

Beijing National Biochip Research Center Sub-center in Ningxia, General Hospital of Ningxia Medical University, College of Clinical Medicine, Ningxia Medical University, Yinchuan 750004, China. *Corresponding author, E-mail:

Objective To investigate the expression of circNR4A1/Hsa-circ-0026352 in breast tumor tissue, peripheral blood, cell lines and its effect on the proliferation and apoptosis of MCF-7 breast cancer cells. Methods Using circRNA microarray, different expression of human circRNAs was found out between the breast cancer tissues and adjacent normal tissues. The expression of circNR4A1 in breast cancer tissues, peripheral blood and breast cancer cell lines including MCF-7, HCC-1937, MDA-MB-231, T-47D and MCF-10A were detected by quantitative real-time PCR (qRT-PCR).

View Article and Find Full Text PDF

We have fabricated a flow-through biochip consisting of passive elements for the analysis of single base mutations in genomic DNA using polycarbonate (PC) as the substrate. The biochip was configured to carry out two processing steps on the input sample, a primary polymerase chain reaction (PCR) followed by an allele-specific ligation detection reaction (LDR) for scoring the presence of low abundant point mutations in genomic DNA. The operation of the device was demonstrated by detecting single nucleotide polymorphisms in gene fragments (K-ras) that carry high diagnostic value for colorectal cancers.

View Article and Find Full Text PDF

We have microfabricated a flow-through biochip for the analysis of single base mutations in genomic DNA using two different materials: (1) a polycarbonate (PC) chip for performing a primary polymerase chain reaction (PCR) followed by an allele-specific ligation detection reaction (LDR) and (2) a poly(methyl methacrylate) (PMMA) chip for the detection of the LDR products using a universal array platform. The operation of the device was demonstrated by detecting low-abundant DNA mutations in gene fragments (K-ras) that carry point mutations with high diagnostic value for colorectal cancers. The PC microchip was used for sequential PCR/LDR in a continuous-flow format, in which the following three steps were carried out: (1) exponential amplification of gene fragments from genomic DNA; (2) mixing of the resultant PCR product with a LDR mixture via a Y-shaped passive micromixer and (3) ligation of two primers only when the particular mutation was present in the genomic DNA.

View Article and Find Full Text PDF

We describe the microfabrication and operational characteristics of a simple flow-through biochip sensor capable of detecting low abundant point mutations in K-ras oncogenes from genomic DNA, which carry high diagnostic value for colorectal cancers. The biochip consisted of an allele-specific ligase detection reaction (LDR) coupled to a universal array for interrogating multiple mutations simultaneously from a clinical sample. The integrated sensing platform was micro-manufactured from two different polymers, polycarbonate, PC, which was used for the LDRs, and poly(methyl methacrylate), PMMA, which was used to build the microarray.

View Article and Find Full Text PDF

We have fabricated a flow-through biochip assembly that consisted of two different microchips: (1) a polycarbonate (PC) chip for performing an allele-specific ligation detection reaction (LDR) and (2) a poly(methyl methacrylate) (PMMA) chip for the detection of the LDR products using an universal array platform. The operation of the device was demonstrated by detecting low-abundant DNA mutations in gene fragments (K-ras) that carry point mutations with high diagnostic value for colorectal cancers. The PC microchip was used for the LDR in a continuous-flow format, in which two primers (discriminating primer that carried the complement base to the mutation being interrogated and a common primer) that flanked the point mutation and were ligated only when the particular mutation was present in the genomic DNA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!